Related Experiment Videos
Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior
Seungrie Han1, Soo Hyun Yang1, Jin Yong Kim1
1Department of Anatomy, College of Medicine, Korea University, Seoul, 136-705, Korea.
Insights
Cholinergic signaling in the habenula is crucial for regulating mood and reward. Down-regulation of these pathways contributes to depression-like behaviors, independent of serotonin.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Cholinergic signaling dysfunction is linked to depression.
- The specific role of habenular cholinergic signaling in depression remains unclear.
Purpose of the Study:
- Investigate the functional impact of habenular cholinergic signaling on depression-like behaviors.
- Determine the relationship between habenular cholinergic signaling and key neuronal pathways implicated in mood regulation.
Main Methods:
- Utilized a chronic restraint stress (CRS) rat model and CHAT::cre transgenic mice.
- Employed gene knockdown, pharmacogenetics (DREADD), and postmortem analysis of human brain tissue.
Main Results:
- Down-regulation of cholinergic genes (CHAT, VACHT, CHT, CHRNA3, CHRNB3, CHRNB4) observed in a rat model of depression.
- Habenular CHAT knockdown induced anhedonia-like behavior, unresponsive to fluoxetine.
- Activation of habenular cholinergic neurons modulated dopamine and serotonin neuron activity.
- Similar gene down-regulation found in the habenula of suicide victims with major depressive disorder (MDD).
Conclusions:
- Habenular cholinergic signaling plays a significant role in regulating depression-like behaviors, particularly anhedonia.
- This pathway's dysfunction is implicated in major depressive disorder (MDD) and may represent a novel therapeutic target.
Abstract:
Dysfunction of cholinergic signaling in the brain has long been believed to be associated with depressive disorders. However, the functional impact of habenular cholinergic signaling on the specified depressive behaviors is not well understood. Here, we demonstrated that the expression levels of cholinergic signaling genes (CHAT, VACHT, CHT, CHRNA3, CHRNB3 and CHRNB4) were down-regulated in a chronic restraint stress (CRS) rat model of depression, in which rats display depression-like behaviors such as anhedonia and mood despair. Moreover, knockdown of CHAT in the rat habenula was sufficient to evoke anhedonia-like behavior. The anhedonia-like behavior induced by CHAT knockdown was not reversed by chronic administration of the selective serotonin reuptake inhibitor fluoxetine. To determine whether habenular cholinergic signaling is associated with regulation of dopamine neurons in the ventral tegmental area (VTA) and serotonin neurons in the dorsal raphe nucleus (DRN), we used CHAT::cre transgenic mice expressing the Designer Receptors Exclusively Activated by Designer Drugs (DREADD). Pharmacogenetic activation of habenular cholinergic neurons induces the excitation of dopamine neurons in the VTA and reduces the immunoreactivity of 5-hydroxytryptamine (5-HT) in the DRN. Habenular cholinergic gene down-regulation was recapitulated in the postmortem habenula of suicide victims diagnosed with major depressive disorder (MDD).